tumefactive การใช้

• Normally a tumefactive demyelinating lesion appears together with smaller disseminated lesions.
• The pathology of the tumefactive demyelinating lesion ( TDL ) is heterogeneous.
• Tumefactive demyelination of the spinal cord is rare but it has been reported
• The possible cognitive dysfunction is also rare in tumefactive cases.
• Tumefactive multiple sclerosis is a demyelinating and inflammatory disease.
• Hence the name " tumefactive multiple sclerosis ".
• There are several conditions can produce tumefactive lesions.
• They normally appear together with normal MS lesions, situation described as tumefactive multiple sclerosis.
• Some of these patients developed tumefactive lesions.
• In these cases it is only possible to speak about tumefactive demyelination ( TD ).
• Unfortunately they are mainly tested for RRMS and its effect in tumefactive lesions is unknown.
• Sometimes Marburg MS is considered a synonym for tumefactive MS, but not for all authors.
• In tumefactive multiple sclerosis, the ring-enhancement is open, not forming a complete ring.
• Depending on where the demyelination takes place and its severity, patients with tumefactive MS have different clinical symptoms.
• Typical tumefactive lesions have been found to be responsive to corticosteroids because of their immunosuppressive and anti-inflammatory properties.
• Normally a tumefactive demyelinating lesion appears together with smaller disseminated lesions separated in time and space, yielding a diagnosis of Multiple Sclerosis.
• Tumefactive demyelinating lesions in NMO are not usual, but they have been reported to appear in several cases mistakenly treated with interferon beta.
• Approximately 2 million people in the world suffer from multiple sclerosis Tumefactive multiple sclerosis cases make up 1 to 2 of every 1000 multiple sclerosis cases.
• It is defined as isolated demyelinating lesions which produce a progressive myelopathy similar to primary progressive MS, and is currently considered inside the Tumefactive Multiple sclerosis.
• This means that only around 2000 people in the world suffer of tumefactive MS . Of those cases, there is a higher percentage of females affected than males.